As of early July 2022, uncertainty persists as SARS-CoV-2 coronavirus mutations continue emerging. According to the World Health Organization, the Omicron BA.x variants are now dominant worldwide.
There is a clear need for strategies to tackle emerging variants and protect populations against potential future threats to human health, says vaccine researchers from the University of Oxford and Caltech.
$30 Million Funding Empowers All-in-One Vaccine Candidate to Tackle Future Coronaviruses
Immunocompromised Hospitalized With COVID-19 Have Poor Outcomes
Immunocompromised patients have increased odds of ICU admission, in-hospital death, regardless of vaccination status
One in 13 U.S. Adults Report Long COVID Symptoms
Rates higher among younger adults and women, with some geographic variation
Resilience and Stress Management Program Aids Health Care Workers
Improvements seen in resilience, stress, anxiety, and burnout-exhaustion after the six-week program
FDA Allows Pharmacists to Prescribe COVID-19 Drug Paxlovid
However, patients who test positive for COVID-19 should still consider reaching out to their regular health care provider for Paxlovid first